Market closed

InMode/$INMD

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About InMode

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.

Ticker

$INMD
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Equipment & Supplies

Headquarters

Yokne'am, Israel

Employees

581
Website
www.inmodemd.com

InMode Metrics

BasicAdvanced
$1.4B
8.75
$1.84
2.17
-

$1.4B

2.17

$26.80

$14.87

858K

10.679

9.586

0.722

0.722

10.50%

21.04%

8.749

3.122

1.68

1.68

8.214

-15.05%

-12.53%

9.56%

1.90%

What the Analysts think about InMode

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for InMode stock.

InMode Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

InMode Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

InMode News

AllArticlesVideos
InMode: Clearly, I Was Too Optimistic (Rating Downgrade)

InMode: Clearly, I Was Too Optimistic (Rating Downgrade)

Seeking Alpha·5 days ago
InMode: Product Origination And Undervaluation Make The Stock A Buy

InMode: Product Origination And Undervaluation Make The Stock A Buy

Seeking Alpha·1 month ago
InMode: $25/Share Is Closer Than You Think

InMode: $25/Share Is Closer Than You Think

Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $INMD

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for InMode stock?

InMode (INMD) has a market cap of $1.4B as of January 15, 2025.

What is the P/E ratio for InMode stock?

The price to earnings (P/E) ratio for InMode (INMD) stock is 8.75 as of January 15, 2025.

Does InMode stock pay dividends?

No, InMode (INMD) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next InMode dividend payment date?

InMode (INMD) stock does not pay dividends to its shareholders.

What is the beta indicator for InMode?

InMode (INMD) has a beta rating of 2.17. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.